KAS Kaspa Price Prediction: 20% Drop OR MORE?!?!?!?!
1 extracted signal · 0 resolved · 0 still active
C-Zar Gets Crypto Independent analyst profile- Source published
- 19 Jun 2026, 13:40 UTC
- Recorded by Tahlil Plus
- 19 Jun 2026, 14:02 UTC

AI-generated source summary
The analysis focuses on KAS/USD, indicating a bearish trend. The current price is approximately $0.02955. The speaker identifies a potential target price of $0.02277, derived from Fibonacci retracement levels. The failure bound for this bearish prediction is set at $0.0333, suggesting that a break above this level would invalidate the bearish outlook. The technical indicators, including RSI and MACD, are interpreted as bearish, with the RSI consistently below 50 and MACD showing bearish momentum. The speaker notes a prolonged period of bearishness and expects further downside movement, with potential support found around 0.02277 and 1.272 Fibonacci extension level. The analysis concludes that the overall market sentiment for KAS/USD is bearish, with no strong bullish signals detected.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
C-Zar Gets Crypto
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
